Effect of DT56a (Femarelle) on the Coagulation System in the Treatment of Postmenopausal Women

Completed

Conditions studied: Menopause, Thrombophilia

In brief

The purpose of this study is to determine if Femeralle (DT56a) has an effect on the coagulation system, measured by platelet adhesion and aggregation, of normal and thrombophilic postmenopausal women.

Key facts

Study ID

NCT00883272

Run by

NYU Langone Health

People needed

32

Starts

2007-01-01

Expected to finish

2009-06-01

Last updated by the study team

2023-08-22

Who can join

Age: 40 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• No previous exogenous estrogen exposure
• Symptomatic Menopause: hot flashes, sleep disturbance, or other symptoms related to estrogen deficiency
• Menopausal (see above)

You may not qualify if…

• History of bleeding or thrombotic disorder
• History of malignancy (particularly Breast Cancer)
• Diabetics
• Coronary Artery Disease
• Liver Disease
• Concurrent Anticoagulation therapy

Where it is running

• 251 East 33rd Street — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.